Importantly, we identified urotensin II receptor–expressing (UTS2R+) NP cells as the postnatal resident stem/progenitor cells and validated the application of ProNPs, combined with ECM specific to their niche, as a potential therapy for IDD. Here, UTS2R is linked to intervertebral disk degenerative disorder.